These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14631564)

  • 21. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic autoantibodies in lupus nephritis.
    Waldman M; Madaio MP
    Lupus; 2005; 14(1):19-24. PubMed ID: 15732283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT; Madaio MP; Shlomchik MJ
    J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis.
    Sainis K; Datta SK
    J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of early nephritis in lupus prone mice with a genetic accelerating (lpr) factor.
    Granholm NA; Cavallo T
    Autoimmunity; 1994; 17(3):195-202. PubMed ID: 7948604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens.
    D'Andrea DM; Coupaye-Gerard B; Kleyman TR; Foster MH; Madaio MP
    Kidney Int; 1996 May; 49(5):1214-21. PubMed ID: 8731084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6/lpr mice: a new approach to modify a lupus murine model.
    Zhu Y; Yue Y; Xiong S
    Clin Exp Immunol; 2018 Sep; 193(3):302-312. PubMed ID: 29704464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-C1q autoantibodies in murine lupus nephritis.
    Trouw LA; Seelen MA; Visseren R; Duijs JM; Benediktsson H; de Heer E; Roos A; van Kooten C; Daha MR
    Clin Exp Immunol; 2004 Jan; 135(1):41-8. PubMed ID: 14678263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of antibodies and B cells in the pathogenesis of lupus nephritis.
    Shlomchik MJ; Madaio MP
    Springer Semin Immunopathol; 2003 May; 24(4):363-75. PubMed ID: 12778333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective role for CCR5 in murine lupus nephritis.
    Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U
    Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1503-15. PubMed ID: 22442210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRAC Channel Controls the Differentiation of Pathogenic B Cells in Lupus Nephritis.
    Li X; Zeng Q; Wang S; Li M; Chen X; Huang Y; Chen B; Zhou M; Lai Y; Guo C; Zhao S; Zhang H; Yang N
    Front Immunol; 2021; 12():779560. PubMed ID: 34745151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice.
    Sekine H; Watanabe H; Gilkeson GS
    J Immunol; 2004 Mar; 172(6):3913-21. PubMed ID: 15004199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
    Anders HJ; Belemezova E; Eis V; Segerer S; Vielhauer V; Perez de Lema G; Kretzler M; Cohen CD; Frink M; Horuk R; Hudkins KL; Alpers CE; Mampaso F; Schlöndorff D
    J Am Soc Nephrol; 2004 Jun; 15(6):1504-13. PubMed ID: 15153561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus.
    Jhou JP; Chen SJ; Huang HY; Lin WW; Huang DY; Tzeng SJ
    Exp Mol Med; 2017 Sep; 49(9):e381. PubMed ID: 28960214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.